Genetics Institute, LLC Sustainability Profile
Genetics Institute, LLC, a leading player in the biotechnology sector, is headquartered in the United States and operates across major regions including North America and Europe. Founded in 2005, the institute has made significant strides in genetic research and personalised medicine, establishing itself as a pioneer in the field. The company specialises in advanced genomic sequencing and analysis, offering unique services that cater to both clinical and research applications. Its innovative approach to genetic testing and data interpretation sets it apart from competitors, ensuring high accuracy and reliability. With a strong market position, Genetics Institute, LLC has achieved notable milestones, including partnerships with renowned research institutions and contributions to groundbreaking studies in genomics. The institute continues to drive advancements in genetic technology, making a lasting impact on healthcare and scientific research.
DitchCarbon Score
How does Genetics Institute, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Genetics Institute, LLC's score of 84 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Genetics Institute, LLC, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Pfizer Inc., which means that any relevant emissions data or climate commitments may be inherited from its parent organisation. As part of its corporate family relationship with Pfizer Inc., Genetics Institute, LLC aligns with the climate initiatives and targets set by Pfizer. This includes commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded from Pfizer Inc. at a first-level relationship. However, specific reduction targets or achievements for Genetics Institute, LLC have not been detailed. While no direct emissions data is available, the overarching commitment to sustainability and climate action is evident through its affiliation with Pfizer, which actively engages in reducing its carbon footprint and addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 964,846,000 | - | - | - | - | - | - | - | 000,000,000 | - | - | - | 000,000,000 |
| Scope 2 | 883,814,000 | - | - | - | - | - | - | - | 000,000,000 | - | - | - | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | 0,000,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 0,000,000,000 |
How Carbon Intensive is Genetics Institute, LLC's Industry?
How Carbon Intensive is Genetics Institute, LLC's Location?
Genetics Institute, LLC's Scope 3 Categories Breakdown
Genetics Institute, LLC's Scope 3 emissions, which increased significantly last year and increased by approximately 821% since 2019, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 77% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 79% of Scope 3 emissions.
Top Scope 3 Categories
Genetics Institute, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Genetics Institute, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
